You downloaded a fitness app, followed it for two weeks, and quietly stopped opening it. Sound familiar? The problem isn't ...
Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology ...
Record Revenues of $4.5 billion in 2025, including a record $1.28 billion in Q4 Record Diluted EPS of $2.05 in 2025, including $0.66 in Q4 Record Net Deposits of $68 billion in 2025, including $16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results